Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Azodi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Minimally Invasive Gynecology|September 29, 2016
Identifying Risk Factors for Urinar y Retention After Hysterectomy for LeiomyomaL Clark Donat, A Tower, M Clark, et al.
The Journal of Surgical Research|January 8, 1999
Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexesF W Sellke, H W Richter, G Dunphy, et al.
Gynecologic Oncology|May 18, 1999
Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degenerationJ B Johns, K O Odunsi, S Fleischman, et al.
The American Journal of Physiology|May 18, 1999
The effects of mannitol, albumin, and cardioplegia enhancers on 24-h rat heart preservationG Dunphy, H W Richter, M Azodi, et al.
Gynecologic Oncology|February 22, 2005
Extrarenal Wilms' tumor of the uterine corpusJ McAlpine, M Azodi, D O'Malley, et al.
Gynecologic Oncology|June 15, 1999
Adenocarcinoma in situ of the cervix: management and outcomeM Azodi, S K Chambers, T J Rutherford, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 25, 2007
Carcinosarcoma of the ovaryD-A Silasi, J L Illuzzi, M G Kelly, et al.
Gynecologic Oncology|December 8, 2004
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiationM G Kelly, D O'Malley, P Hui, et al.
European Journal of Gynaecological Oncology|May 14, 2016
Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcomaM M Abu-Khalaf, M A Raza, C Hatzis, et al.
British Journal of Cancer|April 26, 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyS Bellone, D Roque, E Cocco, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Minimally Invasive Gynecology|September 29, 2016
Identifying Risk Factors for Urinar y Retention After Hysterectomy for LeiomyomaL Clark Donat, A Tower, M Clark, et al.
The Journal of Surgical Research|January 8, 1999
Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexesF W Sellke, H W Richter, G Dunphy, et al.
Gynecologic Oncology|May 18, 1999
Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degenerationJ B Johns, K O Odunsi, S Fleischman, et al.
The American Journal of Physiology|May 18, 1999
The effects of mannitol, albumin, and cardioplegia enhancers on 24-h rat heart preservationG Dunphy, H W Richter, M Azodi, et al.
Gynecologic Oncology|February 22, 2005
Extrarenal Wilms' tumor of the uterine corpusJ McAlpine, M Azodi, D O'Malley, et al.
Gynecologic Oncology|June 15, 1999
Adenocarcinoma in situ of the cervix: management and outcomeM Azodi, S K Chambers, T J Rutherford, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 25, 2007
Carcinosarcoma of the ovaryD-A Silasi, J L Illuzzi, M G Kelly, et al.
Gynecologic Oncology|December 8, 2004
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiationM G Kelly, D O'Malley, P Hui, et al.
European Journal of Gynaecological Oncology|May 14, 2016
Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcomaM M Abu-Khalaf, M A Raza, C Hatzis, et al.
British Journal of Cancer|April 26, 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyS Bellone, D Roque, E Cocco, et al.
Pageof 3